Top Markets
#1 Status Status +24.09%
#2 Ontology Gas Ontology Gas +22.68%
#3 EXOD EXOD +22.08%
#4 ETHGas ETHGas +17.93%
#5 The Black Bull The Black Bull +15.99%
#6 Fake World Assets Fake World Assets +11.81%
#7 aelf aelf +10.18%
#8 Derive Derive +8.58%
#9 Gas Gas +8.36%
#10 Tornado Cash Tornado Cash +7.15%
Coin of the day
Status Status
設定
言語
日本
通貨
USD
テーマ
Promore Pharma AB (publ) Promore Pharma AB (publ)

Promore Pharma AB (publ)

PROMO
株式のランク #25506
Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to... Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to advancing peptide-based drug therapies. The company's development pipeline features PXL01, currently undergoing Phase IIa studies for its potential in preventing post-surgical adhesions and scars, mitigating dermal scarring, and aiding hand tendon repair. Another key asset, LL-37, is engaged in Phase IIb clinical trials to address venous leg ulcers, stimulate the healing of persistent wounds, and treat diabetic foot ulcers. Additionally, Promore Pharma has partnered with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. Founded in 2002, the company, formerly known as Lipopeptide AB until its rebranding in January 2017, maintains its headquarters in Solna, Sweden.
株価
$1.34
最終同期: 2024-02-14
時価総額
$48.96M
変化（1日）
-12.94%
変化（1年）
0.00%
国
SE
取引 Promore Pharma AB (publ) (PROMO)

カテゴリー

Healthcare
Promore Pharma AB (publ)（PROMO）の株価履歴
終値の最高値: $2.11 （2024-02-01）

終値の最安値: $179.71 （2017-07-01）
Promore Pharma AB (publ) の株価履歴（2017 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2024 54.03%
2023 -86.45%
2022 -51.13%
2021 -52.08%
2020 -18.70%
2019 -67.83%
2018 -5.69%
2017 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.84 -18.14%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 8.65%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US